{"id":18614,"date":"2023-05-18T11:38:00","date_gmt":"2023-05-18T03:38:00","guid":{"rendered":"https:\/\/flcube.com\/?p=18614"},"modified":"2024-12-18T12:12:10","modified_gmt":"2024-12-18T04:12:10","slug":"cde-lists-three-home-grown-drugs-for-priority-review-including-myopia-treatment","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=18614","title":{"rendered":"CDE Lists Three Home-Grown Drugs for Priority Review, Including Myopia Treatment"},"content":{"rendered":"\n<p>The Center for Drug Evaluation (CDE) website has indicated that three home-grown drugs are on track to obtain priority review statuses. These include Shenyang Sinqi Pharmaceutical Co. Ltd.\u2019s atropine for arresting the progression of myopia in children, Zhuhai Jinzhidun Pharmaceutical Technology Co., Ltd.\u2019s trientine for hepatolenticular degeneration that cannot tolerate penicillamine, and Jiddi Pharmaceutical Technology (Shanghai) Co.,Ltd.\u2019s carglumic acid for hyperammoniaemia caused by primary deficiency of N-acetylglutamate synthase (NAGS), isovaleralemia (IVA), methylmalonic acid (MMA), or propionic acidemia (PA).<\/p>\n\n\n\n<p><strong>Atropine for Myopia Control<\/strong><br>Low concentration atropine is believed to delay the deepening of myopia in children and achieve the effect of preventing myopia. The concluded Phase III clinical study results showed a statistically significant difference in the main efficacy indicators between the atropine sulfate eye drops group and the placebo group, with good safety. There is no similar product approved for marketing in China, where Ocumension Therapeutics\u2019 OT-101, Arctic Vision\u2019s ARVN002, and Zhaoke Ophthalmology\u2019s NVK002 are under development.<\/p>\n\n\n\n<p><strong>Trientine for Wilson&#8217;s Disease<\/strong><br>Trientine, a copper ion complexing agent originated by Germany&#8217;s Merck KGaA, was first approved in the US for the treatment of hepatolenticular degeneration (Wilson&#8217;s disease) that cannot tolerate penicillamine. The drug, included in the third list of pediatric drugs encouraged for development in China in June 2019, sees generic versions by Deruike Pharma, Orphalan\/ Northrop, and Jiddi Pharma filed for marketing in China, with priority review statuses.<\/p>\n\n\n\n<p><strong>Carglumic Acid for Hyperammonemia<\/strong><br>Carglumic acid, a functional analogue of N-acetylglutamate (NAG) and an activator of carbamoyl phosphate synthase 1 (CPS1) originated by Italy-based Recordati, is used to treat acute and chronic hyperammonemia. The drug, first approved in Europe in January 2003, was filed for marketing in China in March 2022 with priority review status. Meanwhile, China Grand Pharmaceutical and Healthcare Holdings Ltd\u2019s generic version obtained priority review status in August 2022.<a href=\"https:\/\/flcube.com\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Center for Drug Evaluation (CDE) website has indicated that three home-grown drugs are on&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,11],"tags":[2816,31,683,2815,2814,120,44,68,80,469,166],"class_list":["post-18614","post","type-post","status-publish","format-standard","hentry","category-company","category-drug","tag-deruike-pharma","tag-generic-drugs","tag-grand-pharmaceutical","tag-jiddi-pharmaceutical-technology","tag-jinzhidun-pharmaceutical-technology","tag-merck","tag-ophthalmology","tag-pediatric-drugs","tag-priority-reviews","tag-sinqi-pharmaceutical","tag-zhaoke-ophthalmology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>CDE Lists Three Home-Grown Drugs for Priority Review, Including Myopia Treatment - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The Center for Drug Evaluation (CDE) website has indicated that three home-grown drugs are on track to obtain priority review statuses. These include Shenyang Sinqi Pharmaceutical Co. Ltd.\u2019s atropine for arresting the progression of myopia in children, Zhuhai Jinzhidun Pharmaceutical Technology Co., Ltd.\u2019s trientine for hepatolenticular degeneration that cannot tolerate penicillamine, and Jiddi Pharmaceutical Technology (Shanghai) Co.,Ltd.\u2019s carglumic acid for hyperammoniaemia caused by primary deficiency of N-acetylglutamate synthase (NAGS), isovaleralemia (IVA), methylmalonic acid (MMA), or propionic acidemia (PA).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=18614\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CDE Lists Three Home-Grown Drugs for Priority Review, Including Myopia Treatment\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=18614\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-18T03:38:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-18T04:12:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18614#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18614\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"CDE Lists Three Home-Grown Drugs for Priority Review, Including Myopia Treatment\",\"datePublished\":\"2023-05-18T03:38:00+00:00\",\"dateModified\":\"2024-12-18T04:12:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18614\"},\"wordCount\":320,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Deruike Pharma\",\"Generic drugs\",\"Grand Pharmaceutical\",\"Jiddi Pharmaceutical Technology\",\"Jinzhidun Pharmaceutical Technology\",\"Merck\",\"Ophthalmology\",\"Pediatric drugs\",\"Priority reviews\",\"Sinqi Pharmaceutical\",\"Zhaoke Ophthalmology\"],\"articleSection\":[\"Company\",\"Drug\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=18614#respond\"]}],\"copyrightYear\":\"2023\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18614\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=18614\",\"name\":\"CDE Lists Three Home-Grown Drugs for Priority Review, Including Myopia Treatment - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2023-05-18T03:38:00+00:00\",\"dateModified\":\"2024-12-18T04:12:10+00:00\",\"description\":\"The Center for Drug Evaluation (CDE) website has indicated that three home-grown drugs are on track to obtain priority review statuses. These include Shenyang Sinqi Pharmaceutical Co. Ltd.\u2019s atropine for arresting the progression of myopia in children, Zhuhai Jinzhidun Pharmaceutical Technology Co., Ltd.\u2019s trientine for hepatolenticular degeneration that cannot tolerate penicillamine, and Jiddi Pharmaceutical Technology (Shanghai) Co.,Ltd.\u2019s carglumic acid for hyperammoniaemia caused by primary deficiency of N-acetylglutamate synthase (NAGS), isovaleralemia (IVA), methylmalonic acid (MMA), or propionic acidemia (PA).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18614#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=18614\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=18614#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CDE Lists Three Home-Grown Drugs for Priority Review, Including Myopia Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CDE Lists Three Home-Grown Drugs for Priority Review, Including Myopia Treatment - Insight, China&#039;s Pharmaceutical Industry","description":"The Center for Drug Evaluation (CDE) website has indicated that three home-grown drugs are on track to obtain priority review statuses. These include Shenyang Sinqi Pharmaceutical Co. Ltd.\u2019s atropine for arresting the progression of myopia in children, Zhuhai Jinzhidun Pharmaceutical Technology Co., Ltd.\u2019s trientine for hepatolenticular degeneration that cannot tolerate penicillamine, and Jiddi Pharmaceutical Technology (Shanghai) Co.,Ltd.\u2019s carglumic acid for hyperammoniaemia caused by primary deficiency of N-acetylglutamate synthase (NAGS), isovaleralemia (IVA), methylmalonic acid (MMA), or propionic acidemia (PA).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=18614","og_locale":"en_US","og_type":"article","og_title":"CDE Lists Three Home-Grown Drugs for Priority Review, Including Myopia Treatment","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=18614","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2023-05-18T03:38:00+00:00","article_modified_time":"2024-12-18T04:12:10+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=18614#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=18614"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"CDE Lists Three Home-Grown Drugs for Priority Review, Including Myopia Treatment","datePublished":"2023-05-18T03:38:00+00:00","dateModified":"2024-12-18T04:12:10+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=18614"},"wordCount":320,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Deruike Pharma","Generic drugs","Grand Pharmaceutical","Jiddi Pharmaceutical Technology","Jinzhidun Pharmaceutical Technology","Merck","Ophthalmology","Pediatric drugs","Priority reviews","Sinqi Pharmaceutical","Zhaoke Ophthalmology"],"articleSection":["Company","Drug"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=18614#respond"]}],"copyrightYear":"2023","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=18614","url":"https:\/\/flcube.com\/?p=18614","name":"CDE Lists Three Home-Grown Drugs for Priority Review, Including Myopia Treatment - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2023-05-18T03:38:00+00:00","dateModified":"2024-12-18T04:12:10+00:00","description":"The Center for Drug Evaluation (CDE) website has indicated that three home-grown drugs are on track to obtain priority review statuses. These include Shenyang Sinqi Pharmaceutical Co. Ltd.\u2019s atropine for arresting the progression of myopia in children, Zhuhai Jinzhidun Pharmaceutical Technology Co., Ltd.\u2019s trientine for hepatolenticular degeneration that cannot tolerate penicillamine, and Jiddi Pharmaceutical Technology (Shanghai) Co.,Ltd.\u2019s carglumic acid for hyperammoniaemia caused by primary deficiency of N-acetylglutamate synthase (NAGS), isovaleralemia (IVA), methylmalonic acid (MMA), or propionic acidemia (PA).","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=18614#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=18614"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=18614#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"CDE Lists Three Home-Grown Drugs for Priority Review, Including Myopia Treatment"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/18614","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18614"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/18614\/revisions"}],"predecessor-version":[{"id":18617,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/18614\/revisions\/18617"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18614"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18614"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18614"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}